Equillium Announces Positive Interim Data of Itolizumab in the First-line Treatment of Acute Graft-Versus-Host Disease
100% overall response rate in dose cohort 3 and 80% overall response rate across all…
100% overall response rate in dose cohort 3 and 80% overall response rate across all…
– Pivotal Phase 3 safety and efficacy study AEZS-130-P02 (“Study P02”) expected to commence in…
Reported positive topline results for the ACROBAT Edge and Evolve Phase 2 trials of oral…
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL),…
Experienced Financial Executive Brings Leadership and Public Company Expertise BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE)…
HOUSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company…
AUSTIN, TX and DURHAM, NC, Nov. 06, 2020 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck)…
– Manuscript highlights the importance of molecular surveillance of SARS-CoV-2 immune evasion and rational design…
– Live video webcast with the Cocrystal management team, on Thursday, November 12th at 12:00…
ROSELAND, N.J., Nov. 06, 2020 (GLOBE NEWSWIRE) — Emisphere Technologies, Inc. (“Emisphere” or the “Company”)…
Active Biotech AB (publ) (ticker: ACTI) hereby invites analysts, investors and media to its virtual…
First Gene Therapy Candidate OCU400 On Track to Enter the Clinic in 2021 MALVERN, Pa.,…
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company…
Aleafia Health Port Perry Outdoor cannabis cultivation. TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Aleafia…
– Financing led by Ping An Capital – – Phase 2 SPARTA Trial for APL-101…
EnACT study of MAT2203 in cryptococcal meningitis received unanimous Data and Safety Monitoring Board (DSMB)…
SAN FRANCISCO, Nov. 06, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that…
-On track to begin enrollment in the Phase 1 trial for JTX-8064 by year-end 2020-…
MENLO PARK, Calif. and BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq:…
FARMINGTON HILLS, Mich., Nov. 06, 2020 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc., a clinical-stage ophthalmic…